AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Incyte to Report Fourth Quarter and Year-End Financial Results

January 23, 2020 GMT

WILMINGTON, Del.--(BUSINESS WIRE)--Jan 23, 2020--

Incyte (Nasdaq:INCY) announced today that it has scheduled its fourth quarter and year-end 2019 financial results conference call and webcast for 8:00 a.m. ET on Thursday, February 13, 2020.

The schedule for the press release and conference call/webcast is as follows:

  • Q4 & YE 2019 Press Release:

February 13, 2020 at 7:00 a.m. ET

  • Q4 & YE 2019 Conference Call:

February 13, 2020 at 8:00 a.m. ET

  • Domestic Dial-In Number:

877-407-3042

  • International Dial-In Number:

201-389-0864

  • Conference ID Number:

13698234

If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415 . To access the replay you will need the conference ID number 13698234.

The live webcast with slides can be accessed at Investor.Incyte.com and will be available for replay for 30 days.

About Incyte

Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.

View source version on businesswire.com:https://www.businesswire.com/news/home/20200123005007/en/

CONTACT: Incyte Contacts

Media

Catalina Loveman +1 302 498 6171

cloveman@incyte.comInvestors

Michael Booth, DPhil +1 302 498 5914

mbooth@incyte.com

KEYWORD: UNITED STATES NORTH AMERICA DELAWARE

INDUSTRY KEYWORD: PROFESSIONAL SERVICES HEALTH FINANCE GENERAL HEALTH PHARMACEUTICAL BIOTECHNOLOGY

SOURCE: Incyte

Copyright Business Wire 2020.

PUB: 01/23/2020 08:00 AM/DISC: 01/23/2020 08:01 AM

http://www.businesswire.com/news/home/20200123005007/en